GI hemorrhage with fulminant shock induced by jejunal gastrointestinal stromal tumor (GIST) coincident with duodenal neuroendocrine carcinoma (NET) plus neurofibromatosis (NF) -: Case report and review of the literature

被引:26
作者
Kramer, K [1 ]
Siech, M [1 ]
Sträter, J [1 ]
Aschoff, AJ [1 ]
Henne-Bruns, D [1 ]
机构
[1] Univ Ulm Klinikum, Chirurg Klin 1, D-89075 Ulm, Germany
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2005年 / 43卷 / 03期
关键词
GIST; NET; NF; hemorrhage;
D O I
10.1055/s-2004-813810
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The incidence of neuroendocrine tumors (NET) and of gastrointestinal stromal tumors (GIST) is 0.5 and 1 - 2 in 100,000; the prevalence of neurofibromatosis is 1 in 3000 live births in Western countries. Case Report: A 43-year-old white woman with a six-month history of meleana, paleness, vertigo. and fatigue was not referred to any gastrointestinal doctor for diagnostic work-up. Finally, she collapsed and was admitted to hospital because of an acute gastrointestinal bleeding. Endoscopically the source of bleeding could not be localized while blood in the duodenum and proximal jejunum was demonstrable. The source of bleeding could not be identified by endoscopy, CT scan or angiography. The patient developed a fulminant gastrointestinal hemorrhage with hemoglobin levels below 3.5 g%. An emergency laparotomy and pylorus-preventing Whipple operation was performed. Pathological studies showed a GIST with 3.5 cm diameter of the proximal jejunum which was the source of bleeding. Coincidentally a neuroendocrine carcinoma of the duodenum was found. Conclusion: This case is the first presentation of the coincidence of a neuroendocrine carcinoma of the duodenum with a jejunal bleeding gastrointestinal stromal tumor in neurofibromatosis type1 which led to hemorrhagic shock. In neurofibromatosis - even if non-symptomatic - the increased incidence of tumor needs to be considered.
引用
收藏
页码:281 / 288
页数:8
相关论文
共 57 条
  • [1] ALAMOWITCH C, 1982, NOUV PRESSE MED, V11, P3255
  • [2] ARNESJO B, 1973, SCAND J GASTROENTERO, V8, P637
  • [3] Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours
    Arnold, R
    Trautmann, ME
    Creutzfeldt, W
    Benning, R
    Benning, M
    Neuhaus, C
    Jurgensen, R
    Stein, K
    Schafer, H
    Bruns, C
    Dennler, HJ
    [J]. GUT, 1996, 38 (03) : 430 - 438
  • [4] CARCINOID TUMOR OF AMPULLA OF VATER ASSOCIATED WITH CUTANEOUS NEUROFIBROMATOSIS
    BARBER, PV
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1976, 52 (610) : 514 - 517
  • [5] Gastrointestinal stromal tumors.
    Blanke C.D.
    Eisenberg B.L.
    Heinrich M.C.
    [J]. Current Treatment Options in Oncology, 2001, 2 (6) : 485 - 491
  • [6] BLANKE CD, 2001, P ASCO, V80, P1
  • [7] CAPELLA C, 1995, VIRCHOWS ARCH, V425, P547
  • [8] Ampullary adenocarcinoma in Neurofibromatosis Type 1. Case report and literature review
    Costi, R
    Caruana, P
    Sarli, L
    Violi, V
    Roncoroni, L
    Bordi, C
    [J]. MODERN PATHOLOGY, 2001, 14 (11) : 1169 - 1174
  • [9] Malignant gastrointestinal stromal tumors of the small intestine: A review of 50 cases from a prospective database
    Crosby, JA
    Catton, CN
    Davis, A
    Couture, J
    O'Sullivan, B
    Kandel, R
    Swallow, CJ
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (01) : 50 - 59
  • [10] Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with imatinib
    de Silva, MV
    Reid, R
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2003, 9 (01) : 13 - 19